Company Profile

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE461.15-8 (-1.71 % )
PREV CLOSE (Rs.) 469.15
OPEN PRICE (Rs.) 468.90
BID PRICE (QTY) 461.60 (200 )
OFFER PRICE (QTY) 463.10 (99 )
VOLUME 233485
TODAY'S LOW / HIGH (Rs.)459.40 474.70
52 WK LOW / HIGH (Rs.)375.4 678.8
NSE461.00 -8.35 (-1.78 % )
PREV CLOSE(Rs.) 469.35
OPEN PRICE (Rs.) 465.25
BID PRICE (QTY) 461.00 (2880 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5244937
TODAY'S LOW / HIGH(Rs.) 459.50 474.60
52 WK LOW / HIGH (Rs.)370.2 679.3

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.43
TTM EPS (Rs.) -2.12
P/E Ratio 0.00
Book Value (Rs.) 77.46
Face Value (Rs.) 1
MCap (Rs. in Mn) 1106453.32
Price/Earning (TTM) -299041.44
Price/Sales (TTM) 12.09
Price/Book (MRQ) 5.95
PAT Margin (%) -6.22
ROCE (%) -0.49
Incorporation Year : 1993

Management Info :

Israel Makov - Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
20Apr04-20-2019$Sun Pharmaceutical Industries submits shareholding pattern Sun Pharmaceutical Industrie

Sun Pharmaceutical Industries has submitted the Shareholding Pattern for the Period Ended March 31, 2019.

The above information is a part of company’s filings submitted to BSE.

Sun Pharmaceutical Industries has submitted the Shareholding Pa..
11Apr04-11-2019$Pratham Investments informs about disclosure Pratham Investments informs

Pratham Investments has informed about the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The above information is a part of company’s filings submitted to BSE.

Pratham Investments has informed about the disclosure under Reg..
11Apr04-11-2019$Sun Pharmaceutical Industries informs about disclosure Sun Pharmaceutical Industrie

Sun Pharmaceutical Industries has informed about the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayant S Sanghvi.

The above information is a part of company’s filings submitted to BSE.

Sun Pharmaceutical Industries has informed about the disclosure..
09Apr04-09-2019$Sun Pharma's arm to commence distribution of its formulation products in India Sun Pharma's arm to commence

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Distributors will commence distributing its formulation products in India from this month in a phased manner on the same terms as was with Aditya Medisales. This phased transition is expected to be fully completed by the first quarter of 2019-20.

In January, the company had announced that distribution related to the company's India domestic formulations business shall be transitioned from Aditya Medisales to its wholly-owned subsidiary.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun..
09Apr04-09-2019$Sun Pharma trades in green on the BSE Sun Pharma trades in green o

Sun Pharmaceutical Industries is currently trading at Rs. 464.50, up by 2.40 points or 0.52% from its previous closing of Rs. 462.10 on the BSE.

The scrip opened at Rs. 458.00 and has touched a high and low of Rs. 465.65 and Rs. 455.55 respectively. So far 131786 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 375.40 on 18-Jan-2019.

Last one week high and low of the scrip stood at Rs. 473.70 and Rs. 455.55 respectively. The current market cap of the company is Rs. 111293.15 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.53% and 13.09% respectively.

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Distributors will commence distributing its formulation products in India from this month in a phased manner on the same terms as was with Aditya Medisales. This phased transition is expected to be fully completed by the first quarter of 2019-20.

In January, the company had announced that distribution related to the company's India domestic formulations business shall be transitioned from Aditya Medisales to its wholly-owned subsidiary.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharmaceutical Industries is currently trading at Rs. 464.5..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit-386.8-4945.9
Gross Profit -650.7 -5199.8
Operating Profit 2023.712510.6
Net Sales 22612.679476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Dr. Reddys Lab (BSE)
 2924.15 (2.41%)
M.Cap ( in Cr)
48560.17
Jenburkt Pharma (BSE)
 496.40 (2.60%)
M.Cap ( in Cr)
227.82
Aurobindo Pharma (BSE)
 795.60 (1.41%)
M.Cap ( in Cr)
46615.45
Astrazeneca Pharma I (BSE)
 2262.85 (0.46%)
M.Cap ( in Cr)
5657.13
Everest Organics (BSE)
 204.45 (5.01%)
M.Cap ( in Cr)
163.56
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.31 %
FI/BANKS/INSURANCE 7.8 %
PROMOTERS 54.38 %
NON-INSTITUTION 12.76 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested